Skip to main content
. 2011 Nov 15;73(5):801–811. doi: 10.1111/j.1365-2125.2011.04142.x

Table 4.

Most frequently self-reported clinical incident events in 7 month study observation period, ranked by total count, by vaccine exposure cohort

Follow-up period (month after vaccinated or offered vaccination)

Incident events 1 2 3 4 5 6 7 Total Number per 1000 patient months of follow-up
Received H1N1 vaccine
 Chest infection 10 14 14 10 5 0 0 53 2.91
 Coryza 5 8 6 1 3 1 0 24 1.32
 Malaise 12 4 4 1 0 0 0 21 1.15
 Cough 5 7 2 1 4 0 0 19 1.04
 Allergy 9 1 1 1 0 0 0 12 0.66
 Flu like symptoms 2 3 2 1 3 1 0 12 0.66
 Pyrexia 7 4 1 0 0 0 0 12 0.66
 Dyspnoea 1 4 2 1 2 1 0 11 0.60
 Pharyngitis 4 2 3 0 2 0 0 11 0.60
 Pain in limb 3 1 4 1 1 0 0 10 0.55
 Headache 1 0 5 1 2 0 0 9 0.49
 Myalgia 2 2 2 1 1 0 0 8 0.44
 Rash 2 1 3 1 1 0 0 8 0.44
 Diarrhoea 3 1 1 2 0 0 0 7 0.38
 Chest pain 1 1 1 2 2 0 0 7 0.38
 Sinusitis 1 0 0 2 2 2 0 7 0.38
 Viral infection 0 2 0 3 1 0 0 6 0.33
 Influenza 3 2 0 1 0 0 0 6 0.33
 Nausea 3 1 0 2 0 0 0 6 0.33
 Pain 4 0 2 0 0 0 0 6 0.33
Did not receive H1N1 vaccine
 Chest infection 0 4 0 0 1 0 0 5 3.98
 Coryza 0 2 0 0 0 0 0 2 1.59
 Angina 0 0 1 0 0 0 0 1 0.80
 Asthma worse 0 0 0 1 0 0 0 1 0.80
 Carcinoma stomach 0 1 0 0 0 0 0 1 0.80
 Cardiac failure 0 1 0 0 0 0 0 1 0.80
 Cardiovascular system unspecified* 0 0 1 0 0 0 0 1 0.80
 Constipation 0 0 0 1 0 0 0 1 0.80
 Dyspnoea 0 0 1 0 0 0 0 1 0.80
 Fracture 0 0 1 0 0 0 0 1 0.80
*

Patient verbatim term given as ‘heart problems’.